Experiment 68640
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | WILKINSON,D: MURRAY,J:. (2001). GALANTAMINE: A RANDOMIZED,DOUBLE-BLIND,DOSE COMPARISON IN PATIENTS WITH ALZHEIMER'S DISEASE.. 16(9) |
| Amount utilized | |
| Compound isolated | |
| Disease | TO INVESTIGATE WHETHER GALANTAMINE SIGNIFICANTLY IMPROVES THE CORE SYMPTOMS OF ALZHEIMER'S DISEASE (AD).METHOD A MULTICENTRE, RANDOMIXED, PARALLEL, DOUBLE-BLIND,PLACEBO-CONTROLLED TRIAL WAS CARRIED OUT TO EVALUATE THE EFFICACY AND TOLERABILITY O GALANTAMINE 18,24 MG/DAY ADMINISTERED FOR 3 MONTHS IN 285 PATIENTS WITH MILD-TO-MODERATE PROBABLE AD. RESULTS: PATIENTS TREATED WITH GALANTAMINE 24 MG/DAY HAD A SIGNIFICANTLY BETTER OUTCOME THAN PLACEBO ON ADAS-CO;THIS STUDY SHOWS THEAT , RELATI TO PLACEBO, GALANTAMINE SIGNIFICANTLY IMPROVES THE CORE SYMPTOMS OF ALZHEIMER'S DISEASE. |
| Dose amount | VAR |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Dose expression | DOSE |
| Gender | GIVEN TO BOTH SEXES |